Showing results (261-270 of 631) with videos related to

Sort By:
Pageof 64
ACS Chemical Biology|December 14, 2011
Targeting diverse signaling interaction sites allows the rapid generation of bivalent kinase inhibitorsZachary B Hill, B Gayani K Perera, Simeon S Andrews, et al.
Journal of Pediatric Psychology|February 8, 2017
Siblings of Children With a Complex Chronic Health Condition: Maternal Posttraumatic Growth as a Predictor of Changes in Child Behavior ProblemsEllen Stephenson, Anita DeLongis, Rose Steele, et al.
Cephalalgia : an International Journal of Headache|November 17, 2012
NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine modelsDeepak K Bhatt, Saurabh Gupta, Inger Jansen-Olesen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2023
An Analysis of Dosing-Related Postmarketing Requirements for Novel Oncology Drugs Approved by the U.S. Food and Drug Administration, 2012-2022Grace Collins, Brittany McKelvey, Hillary S Andrews, et al.
Dalton Transactions (Cambridge, England : 2003)|September 16, 2025
Investigating the DNA binding properties of two new RuII(dppz) complexes incorporating the facially coordinated ligands tris(pyridin-2-yl)methylamine and di(pyridin-2-yl)methylamineThomas S Andrews, Craig Robertson, Anthony J H M Meijer, et al.
Chembiochem : a European Journal of Chemical Biology|January 16, 2013
Label transfer reagents to probe p38 MAPK binding partnersSimeon S Andrews, Zachary B Hill, B Gayani K Perera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2024
Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection: A Randomized Phase 2 Trial of RSLV-132James S Andrews, Jim B Boonyaratanakornkit, Eva Krusinska, et al.
Pageof 64